Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study

Abstract

BackgroundPrescription opioid misuse has become a leading cause of unintentional injury and death among adolescents and young adults in the United States. However, there is limited information on how adolescents and young adults obtain prescription opioids. There are also inadequate recent data on the prevalence of additional drug abuse among those misusing prescription opioids. In this study, we evaluated past-year prevalence of prescription opioid use and misuse, sources of prescription opioids, and additional substance use among adolescents and young adults.Methods and findingsThis was a retrospective analysis of the National Survey on Drug Use and Health (NSDUH) for the years 2015 and 2016. Prevalence of opioid use, misuse, use disorder, and additional substance use were calculated with 95% confidence intervals (CIs), stratified by age group and other demographic variables. Sources of prescription opioids were determined for respondents reporting opioid misuse. We calculated past-year prevalence of opioid use and misuse with or without use disorder, sources of prescription opioids, and prevalence of additional substance use. We included 27,857 adolescents (12–17 years of age) and 28,213 young adults (18–25 years of age) in our analyses, corresponding to 119.3 million individuals in the extrapolated national population. There were 15,143 respondents (27.5% [95% CI 27.0–28.0], corresponding to 32.8 million individuals) who used prescription opioids in the previous year, including 21.0% (95% CI 20.4–21.6) of adolescents and 32.2% (95% CI 31.4–33.0) of young adults. Significantly more females than males reported using any prescription opioid (30.3% versus 24.8%, P < 0.001), and non-Hispanic whites and blacks were more likely to have had any opioid use compared to Hispanics (28.9%, 28.1%, and 25.8%, respectively; P < 0.001). Opioid misuse was reported by 1,050 adolescents (3.8%; 95% CI 3.5–4.0) and 2,207 young adults (7.8%; 95% CI 7.3–8.2; P < 0.001). Male respondents using opioids were more likely to have opioid misuse without use disorder compared with females (23.2% versus 15.8%, respectively; P < 0.001), with similar prevalence by race/ethnicity. Among those misusing opioids, 55.7% obtained them from friends or relatives, 25.4% from the healthcare system, and 18.9% through other means. Obtaining opioids free from friends or relatives was the most common source for both adolescents (33.5%) and young adults (41.4%). Those with opioid misuse reported high prevalence of prior cocaine (35.5%), hallucinogen (49.4%), heroin (8.7%), and inhalant (30.4%) use. In addition, at least half had used tobacco (55.5%), alcohol (66.9%), or cannabis (49.9%) in the past month. Potential limitations of the study are that we cannot exclude selection bias in the study design or socially desirable reporting among participants, and that longitudinal data are not available for long-term follow-up of individuals.ConclusionsResults from this study suggest that the prevalence of prescription opioid use among adolescents and young adults in...

Assessment of Prescription Opioid Medical Use and Misuse Among Parents and Their Adolescent Offspring in the US

“…Almost 50% of adolescents who misuse prescription opioids report getting them from friends or relatives. 11 Understanding the parental origins of adolescent prescription opioid medical use and misuse has important public health implications, because adolescent prescription opioid use is associated with increased morbidity and mortality. Youths who use prescription opioids are more likely to be diagnosed with an opioid use disorder at 25 years of age 12 and to experience substance-related morbidity, pharmacotherapy for alcohol use disorder, conviction for a substance-related crime, 13 suicide, 14 overdose, and death.…”

Homeopathy Deserves Its Own Scientific Identity

“…An example: in the USA, 27.5% of young people (between 12 and 25) used prescription opioids in the previous year. 8 The Cochrane Collaboration found that only 44% of all patients found moderate relief in neuropathic pain by the opioid Oxycodone and 27% found the same relief from placebo. 9 This implies that 5.7 patients (number needed to treat, NNT) had to be treated to obtain one result from the real medicine.…”

Addressing the context and consequences of substance use, misuse, and dependence: A global imperative

“…Among those who had filled opioid prescriptions, nearly three-quarters were prescribed a mean daily dose lower than the threshold needed to trigger most risk stratification algorithms. Also noteworthy is the analysis of 2015–2016 data from the US National Survey on Drug Use and Health (NSDUH) by Joel Hudgins and colleagues [22]. These authors found that approximately 1 in 20 adolescents and young adults reported either past-year opioid use disorder or past-year nonmedical use of prescription opioids and that three-quarters of those reporting nonmedical use of prescription opioids had obtained them from outside the healthcare system.…”